Facilities of the Cell-Based Technology Department of the VIRTUS Clinic
Cellular therapy or cell transplantation (also called cytotherapy) is a promising direction in medicine, providing safe and effective treatment of diseases.
Due to the cells derived from the patient’s own tissues, cell-based technologies allow regenerating the structure and function of damaged organs or tissues, reducing the signs of aging and enhancing the quality of life.
More than 2500 patients of the VIRTUS Institute have already taken the course of effective cell therapy treatment.
The Department of Cell-Based Technology at the VIRTUS Institute provides:
The patients have a thorough medical check (biochemical, immunological, microbiological, virological, oncology screening tests). Accurate diagnostics proves the efficiency and safety of patient’s biomaterial (as cell-based medical preparations are made from the patient’s own tissues);
- cultivation of human cells and tissues
The cells grown in the SmartCell laboratory are to be analyzed through genetic, immunological, microbiological and other types of specific studies, proving their safety. The laboratory issues a quality certificate for each cell-based medicinal product before starting the patient’s treatment;
- cryogenic storage of cells
- introduction of cell-based medical preparations (systemic or local)
Распаковка биоматериала, подготовленного в лаборатории SmartCell
In the anti-aging procedures, the cell-based medical preparation is injected into the skin of face; in the treatment of joint diseases – the cell-based medical preparation is injected into the joint area; in the treatment of systemic diseases – the cell-based medical preparation is injected intravenously.
Disease Treatment By Means of Stem Cells
Cell therapy and cell-based technologies provide effective and safe treatment of severe diseases caused by organ damage. Stem cells have a unique ability to transform into any type of cell. After their introduction into the body, the tissues and functions of affected organ present the progressive recovery. The disease manifestation is significantly reduced and the patient’s physical well-being improves.
Using of stem cells in medicine helps the whole organism return to normal, avoid the disease complications and thus, enhance the quality of patient’s life.
Stem cell therapy for diabetes helps regenerate damaged pancreatic tissues and increase the production of the patient’s own insulin. As a result of cell therapy, the patient may need less insulin injections or none at all.
Cell-based technologies are also used to treat complications of diabetes mellitus that makes the entire body suffer (the vessels, retina, kidneys and nervous tissue, in particular). Cell therapies for diabetes complications result in the successful regenerative process of damaged tissues and body functioning.
Treatment of liver cirrhosis by means of stem cells – especially at an early stage – makes it possible to restore the structure and functions of the organ in the natural way, without using expensive implantation. After the introduction of stem cells, the damaged liver is regenerated, hepatic metabolism processes in the body return to normal.
Services and Procedures in Cell Therapy
The Cell-Based Technology Department of the VIRTUS Institute of Advanced Medicine provides the following services and procedures for Medical Aesthetics and Regenerative Medicine:
- rejuvenation (anti-aging) and regeneration of the body by means of stem cells; prevention and treatment of diseases or their complications;
- bioinsurance – creation and storage of the stem cell reserve that can be used for body rejuvenation, treatment or recovery after severe illnesses. In case of having no age-related changes or diseases, the patients of the VIRTUS Institute have a unique opportunity to save a sample of their skin tissue for further fibroblast cultivation in the SmartCell laboratory – either to regain health and youth or prevent skin fading.
Cell-based technologies have been successfully used in medical asthetics for the prevention and correction of the signs of aging, as well. The Institute of Advanced Medicine VIRTUS presents its own patented technique of rejuvenation without surgery – neofibrolifting The introduction of autologous fibroblasts into the skin provides its tightness and elasticity, prevents the uneven skin tone and smoothes the wrinkles. The effect of skin rejuvenation after the neofibrolifting procedure intensifies within 1.5 years and keeps for long – up to 5 years.
Stem Cell Treatment Consultation
Stem cell treatment in Odessa at the VIRTUS Institute of Advanced Medicine begins with a doctor’s consultation. If planning aesthetic procedures,you need consulting a dermatologist and a cosmetologist. In case of desease treatment, the consultation is held directly by the Head of the VIRTUS Clinic – Doctor of Medical Sciences, Professor Vladimir Alexandrovich Tsepkolenko.
If necessary, specialized doctors of the Clinic (a gastroenterologist, a neuropathologist, an endocrinologist) may also take part in the initial consultation (it depends on the case). Shared decision-making helps select the most effective strategy of stem cell treatment.
To facilitate therapeutic action, the required amount of cell-based medical preparation and the frequency of its administration are calculated. Then the patient is administered a list of diagnostic medical tests, including:
- general and biochemical blood test;
- urine test;
- tests for HIV and viral hepatitis;
- oncology screening tests.
In 5-7 days, at the next consultation, the doctor fixes the date of cell sampling. The third stage of preparation for stem cell treatment is the collection of biomaterial for cultivation in the SmartCell laboratory. It is performed in the operating room of the VIRTUS Institute under local anesthesia by the highly experienced surgeon.
Popular questions
How to understand that there are problems that need stem cell treatment?
Cellular technologies in regenerative medicine are used to eliminate the signs of aging of the body (deterioration of memory and working capacity, decreased libido, drops in blood pressure, and others). Stem cells are also used for the treatment of chronic diseases (diabetes, autoimmune diseases of the central nervous system, arthrosis, arthritis, and others) and in case of ineffectiveness of other types of therapy.
What tests are prescribed before stem cell treatment?
Before starting stem cell treatment, the patient passes blood tests (general and biochemical), urinalysis, oncological screening tests, as well as tests for HIV and viral hepatitis.
How to prepare for a doctor's consultation?
If the treatment of chronic diseases is necessary, the patient is recommended to bring his outpatient card to the appointment, which shows all the tests and examinations, as well as the methods of treatment that he received during at least the last two years.
Wish to see Before and After examples?
Results of our operations and procedures
convince better than any words. Judge for yourself!
Experienced and responsive doctor. I received a meaningful consultation and good attitude.
I applied for plasmapheresis service. I received good service in safe and comfortable conditions.
I can unreservedly recommend Dr. Serhiy Grigorovich to everyone
Andriy, 19.08.2025
Everything is done perfectly
Bohatyi Peter, 12.08.2025
My husband and I come to the clinic for plasmapheresis, not the first month, Serhiy Grigorovich does plasmapheresis, a very good doctor, an expert in his field, always friendly, smiling, everything goes quickly and without problems, we are sincerely grateful for such a warm welcome and good attitude!🥰
Dyrda Khrystyna, 12.08.2025
*The price is as of September 18, 2025 and is subject to change over time.
Service or type of diagnostics | Odessa Sudnobudivna, 1B | Kyiv Kostiantynivska, 57
|
---|
Service or type of diagnostics | |
---|
- Odessa, Sudnobudivna, 1B
- Kyiv, Kostiantynivska, 57
|
Select branch |
---|
Cell technologies | | |
Забор материала для приготовления клеточного продукта (костный мозг, жировая ткань, кожа) | 5000 | - |
Забор костного мозга для приготовления клеточного препарата (МСК) | | 10500 |
Забор кожи для приготовления клеточного препарата (ДФБ) | | 5500 |
Забор материала для препарата аутологических тромбоцитов | | 3500 |
Однократный перенос даты введения препарата сроком до 6 месяцев | 8500 | 8500 |
Дополнительное банкирование одной порции клеток (1 пробирка) | 20000 | |
| | |
Препарат с 15 млн. дермальных фибробластов (ДФБ) | 34000 | - |
Препарат с 30 млн. дермальных фибробластов (ДФБ), SmartCell red 35+ | 42500 | 42500 |
Препарат с 60 млн. дермальных фибробластов (ДФБ), SmartCell red 45+ | 62500 | 62500 |
Препарат с 120 млн. дермальных фибробластов (ДФБ), SmartCell red 55+ | 82500 | 82500 |
| | |
PRP-препарат (плазма крови обогащенная тромбоцитами) до 14 мл. | 9500 | - |
АМК-препарат (аутомезоконцентрат тромбоцитов) до 12 мл. (АМК-капли) | 14000 | - |
АМК-препарат (аутомезоконцентрат тромбоцитов) до 24 мл. | 16000 | 17000 |
АМК-препарат (аутомезоконцентрат тромбоцитов) до 36 мл. | 18000 | - |
АМК-препарат (аутомезоконцентрат тромбоцитов) до 24 мл., раствор для инъекций, 1 порция PRP | 18000 | - |
АМК-препарат (аутомезоконцентрат тромбоцитов) до 12 мл., раствор для инъекций + капли | 17500 | - |
АМК-капли (аутомезоконцентрат тромбоцитов) до 12 мл. | 5000 | 8000 |
АМК “крем” (аутомезоконцентрат тромбоцитов), “флюид” 30 мл. | 6000 | 6000 |
АМК “флюид” под глаза (аутомезоконцентрат тромбоцитов) | - | 6000 |
Дополнительная выдача продукта (за каждую порцию) | 1300 | 2850 |
Дополнительное введение продукта (за каждую порцию) | | 2000 |
Введение клеточного продукта ДФБ (за одну порцию) | | 10500 |
| | |
Препарат меланоцитарно-кератиноцитарной смеси для лечения витилиго площадью до 25 кв.см. (минимальная доза, однократное введение) | 45000 | 45000 |
Введение клеточного препарата КМС (за одну порцию) | 15500 | 15500 |
| | |
Препарат мезенхимальних стволовых клеток 10 млн. (МСК) | 67000 | - |
Препарат мезенхимальних стволовых клеток 50 млн. (МСК) | 80000 | 80000 |
Препарат мезенхимальних стволовых клеток 100 млн. (МСК) | 127000 | 127000 |
Препарат мезенхимальних стволовых клеток 150 млн. (МСК) | 165000 | 165500 |
| | |
Липофилинг объемом до 50 мл. | - | - |
Липофилинг объемом от 51 мл до 100 мл. | 16000 | - |
Липофилинг объемом от 101 мл до 350 мл. | - | - |
Липофилинг объемом от 351 мл до 500 мл. | 32500 | - |
Липофилинг объемом более 500 мл. | 35000+ | - |
| | |
Создание препарата собственных дермальных фибробластов | 35000 | 35000 |
Создание препарата собственных мезенхимальных стволовых клеток | 60000 | 60000 |
| | |
Криогенное хранение биоматериала 1 год | 4500 | 5000 |
Криогенное хранение биоматериала 3 года (при условии осуществления полной оплаты одним платежом) | 11500 | 12000 |
| | |
15 млн дермальных фибробластов (единоразово) | 28000 | |
30 млн дермальных фибробластов (1 порция х 30 млн клеток) | 36500 | 36500 |
60 млн дермальных фибробластов (2 порции х 30 млн клеток) | 55500 | 55500 |
120 млн дермальных фибробластов (2 порции х 60 млн клеток) | 75500 | 75500 |
Введение клеточного продукта МСК (за одну порцию) | | 15500 |
| | |
До 10 млн мезенхимальных стволовых клеток (1 порция х до 10 млн клеток) | 46500 | |
50 млн мезенхимальных стволовых клеток (1 порция х до 50 млн клеток) | 73500 | 73500 |